Abstract
This cohort study assesses the long-term associations of the US Food and Drug Administration Unapproved Drug Initiative with market exclusivity characteristics and price changes.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Drug Approval* / methods
-
Drug Approval* / organization & administration
-
Drug Costs / legislation & jurisprudence
-
Drug Industry* / economics
-
Drug Industry* / legislation & jurisprudence
-
Drugs, Generic / economics
-
Economic Competition*
-
Humans
-
Orphan Drug Production
-
United States